These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7565850)

  • 21. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-trouble: three cases with simultaneous stent thrombosis in different coronary arteries.
    van Werkum JW; Seesing TH; Suttorp MJ; Bal ET; den Heijer P; Ten Berg JM
    J Interv Cardiol; 2007 Apr; 20(2):132-5. PubMed ID: 17391221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intracardiac thrombosis in myocardial infarction].
    Sudo K
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():169-72. PubMed ID: 17952991
    [No Abstract]   [Full Text] [Related]  

  • 24. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 27. Warfarin, aspirin, or both after myocardial infarction.
    Amit G; Ilia R; Zahger D
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530435
    [No Abstract]   [Full Text] [Related]  

  • 28. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
    Olivier AC; Hollman JL
    J Invasive Cardiol; 2006 Jun; 18(6):E185-7. PubMed ID: 16775899
    [No Abstract]   [Full Text] [Related]  

  • 29. [A 78-year-old man with anterior chest pain].
    Ohashi N; Sumii K; Inoue R; Nakanishi T; Gomyo Y
    J Cardiol; 2004 Jun; 43(6):293-5. PubMed ID: 15248305
    [No Abstract]   [Full Text] [Related]  

  • 30. Wall passivation for unstable angina.
    Lettino M; Dailey-Sterling F; Badimon L; Chesebro JH; Badimon JJ
    Semin Interv Cardiol; 1996 Mar; 1(1):60-6. PubMed ID: 9552495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet therapy with aspirin: from clinical trials to practice.
    Goodnight SH
    Thromb Haemost; 1995 Jul; 74(1):401-5. PubMed ID: 8578495
    [No Abstract]   [Full Text] [Related]  

  • 32. A guide for diagnosis of patients with arterial and venous thrombosis.
    Quinn C; Hill J; Hassouna H
    Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis.
    Agnelli G
    Cardiovasc Res; 1996 Feb; 31(2):232-4. PubMed ID: 8730398
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.
    Blackshear JL; Baker VS; Holland A; Litin SC; Ahlquist DA; Hart RG; Ellefson R; Koehler J
    Arch Intern Med; 1996 Mar; 156(6):658-60. PubMed ID: 8629878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A national survey of Canadian practice patterns of warfarin after anterior wall myocardial infarction in the current era of dual antiplatelet therapy.
    Schwalm JD; Ahmad M; Eikelboom JW; Natarajan MK
    Am J Cardiol; 2010 Jun; 105(12):1844. PubMed ID: 20538142
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L
    Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.